---
title: "InflaRx regains Nasdaq bid price compliance"
url: "https://aibio.space/news/inflarx-regains-nasdaq-bid-price-compliance/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-04-28"
section: "Listings"
tickers: "NASDAQ:IFRX"
source: "https://www.sec.gov/Archives/edgar/data/1708688/000114036126017448/ef20071644_ex99-1.htm"
summary: "Nasdaq's notice dated April 27, 2026 says the ordinary shares closed at $1.00 or more for 10 consecutive business days. The matter is closed."
---

By the aibio.space news desk.

Sources

- [InflaRx N.V. 6-K (2026-04-28)](https://www.sec.gov/Archives/edgar/data/1708688/000114036126017448/ef20071644_ex99-1.htm)

[IFRX](https://aibio.space/companies/inflarx-n-v/)

2026-04-28

# InflaRx regains Nasdaq bid price compliance

Tickers [IFRX](https://aibio.space/companies/inflarx-n-v/)

Nasdaq's notice dated April 27, 2026 says the ordinary shares closed at $1.00 or more for 10 consecutive business days. The matter is closed.

## Key facts

- **Company**: InflaRx N.V. (NASDAQ: IFRX)

- **News type**: Listings

- **Primary source**: [InflaRx N.V. 6-K (2026-04-28)](https://www.sec.gov/Archives/edgar/data/1708688/000114036126017448/ef20071644_ex99-1.htm)

*The stone facade of a federal building. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

InflaRx N.V., which is based in Jena, Germany, said on April 28, 2026 that it has regained compliance with Nasdaq's minimum bid price requirement. It received a written notice dated April 27, 2026 from the Listing Qualifications Department of The Nasdaq Stock Market LLC.

The rule is Nasdaq Listing Rule 5450(a)(1). According to the notice, the closing bid price of the company's ordinary shares was $1.00 per share or greater for 10 consecutive business days, from April 13, 2026 to April 24, 2026. Nasdaq said the matter is now closed.

A minimum bid price rule sets the lowest price per share at which a stock may trade and stay listed on the exchange. The company's ordinary shares are listed on Nasdaq under the symbol "IFRX".

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

IFRX

InflaRx N.V.

NASDAQ · Germany

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/inflarx-regains-nasdaq-bid-price-compliance/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "InflaRx regains Nasdaq bid price compliance", 2026-04-28, https://aibio.space/news/inflarx-regains-nasdaq-bid-price-compliance/